Conventus Orthopaedics' DRS Implant Receives FDA Clearance

Spinal Tech

Conventus Orthopaedics has received FDA 510(k) clearance for its Conventus DRS Implant to treat distal radius fractures. The implant is designed to be less invasive for orthopedic surgeons, according to the release. Surgeons can treat a bread range of distal radius fractures without sacrificing stability.

The device also underwent a clinical study in Europe.

More Articles on Devices:
Johnson & Johnson's Synthes Acquisition Adds 5.6% 4Q Sales Growth
Stryker Reports 4.2% Net Sales Growth in 2012, Hampered by $133M in Recall Charges
Smith & Nephew Wound Device Could Lower Healthcare Costs

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Whitepapers